Gene Expression Signatures for Broad-Spectrum Skin Agent Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing skin care agents struggle to address the complex, multifactorial etiologies of skin conditions like acne, atopic dermatitis, dandruff, and psoriasis, due to the diffuse and low-level effects of cosmetic agents, which are not well-suited for connectivity mapping protocols designed for pharmaceutical agents.
Innovation Solution
The development of a method using gene expression signatures to evaluate the influence of perturbagens on skin homeostasis, enabling the identification of cosmetic agents effective across multiple skin conditions by constructing a connectivity map that accounts for diffuse and systemic effects of cosmetic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If connectivity mapping protocols designed for pharmaceutical agents are used to evaluate cosmetic agents, then the evaluation can leverage existing pharmacological databases and methods, but the diffuse and low-level effects of cosmetic agents cannot be adequately detected or measured
Solution Approach 1:
The patent transforms the evaluation parameters from traditional pharmacological endpoints to gene expression-based metrics. By measuring changes in gene expression profiles rather than relying on conventional phenotypic assays, the method achieves sufficient sensitivity to detect the subtle, diffuse effects of cosmetic agents while maintaining high-throughput evaluation capabilities through standardized protocols.
Solution Approach 2:
The patent replaces traditional mechanical/phenotypic observation methods with molecular-level gene expression analysis. Instead of measuring visible phenotypic changes or using complex mechanical assays, the method uses transcriptomic profiling to detect subtle biological effects, thereby achieving higher measurement precision for cosmetic agent evaluation.
2Adaptability or versatility
If traditional skin condition treatment methods are used, then each skin condition can be addressed with condition-specific therapies, but the complexity of multifactorial etiologies cannot be effectively managed and broad-spectrum treatments cannot be developed
Solution Approach 1:
The patent creates a universal evaluation platform using gene expression signatures that can assess multiple skin conditions simultaneously. By identifying common transcriptional responses across different skin disorders (acne, atopic dermatitis, psoriasis, etc.), the method enables broad-spectrum cosmetic agents to be evaluated and developed for multiple indications, reducing overall complexity despite the multifactorial nature of skin conditions.
Solution Approach 2:
The patent segments the complex evaluation process into distinct gene expression signature profiles for different skin conditions. By creating condition-specific transcriptional signatures that can be independently analyzed and compared, the method manages complexity through systematic categorization while maintaining the ability to identify cross-cutting therapeutic targets.
3Measurement precision
If gene expression signatures are used to evaluate cosmetic agents, then diffuse and systemic effects can be detected and measured, but the evaluation process becomes more complex and requires advanced data analysis
Solution Approach 1:
The patent introduces gene expression signatures as intermediary markers that translate subtle cosmetic agent effects into measurable transcriptional changes. These signatures act as mediators between the diffuse biological effects of cosmetic agents and detectable evaluation endpoints, enabling precise measurement while simplifying data interpretation through standardized signature profiles.
Solution Approach 2:
The patent performs preliminary characterization of gene expression signatures for multiple skin conditions before evaluating cosmetic agents. By pre-establishing condition-specific transcriptional profiles and normalization standards, the method reduces the complexity of real-time data analysis during agent evaluation, allowing researchers to focus on comparing test agent effects against established reference signatures.
Data Source
Figure 1
Figure 1
Figure 1
AI summary
Methods and systems for constructing a gene expression signature representative of a number of biological conditions, systems and methods for determining functional relationships between a skin-active agent and skin conditions of interest, and methods and systems for identifying skin-active agents with broad spectrum activity are provided.